Matt, you’re aware that cannpal has completed significantly more...

Matt, you’re aware that cannpal has completed significantly more research than auscann, including randomised-controlled clinical studies, right? And it looks like auscann has had a number of experienced CEO’s come and go in the same period.

I also don’t see many other Australian cannabis Companies with an IND filed with the FDA, something that Layton and his team have been able to achieve, notwithstanding the size of the Company.

I suggest you do your research before letting your emotions override your logic.